Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
1.
NPG Neurologie - Psychiatrie - Geriatrie ; 2023.
Article in English, French | Scopus | ID: covidwho-2324322

ABSTRACT

Vaccination recommendations for the prevention of herpes zoster (HZ) aim to reactivate specific cell-mediated immunity towards the varicella/zoster virus. This specific immunity naturally declines with age but there are many factors that can accelerate this decline, including, most recently, the immune response induced by SARS-CoV-2. Two vaccines are available to date. A live attenuated vaccine (Zostavax®) licensed in 2006 and more recently a recombinant vaccine (Shingrix®). We present data on the efficacy of these two vaccines as well as on the relevant precautions and safety of use. © 2023 Elsevier Masson SAS Les recommandations vaccinales en matière de prévention du zona ont pour objectif de réactiver l'immunité à médiation cellulaire spécifique contre le virus varicelle-zona. Cette immunité spécifique décline naturellement avec l'âge mais nombreux sont les facteurs qui peuvent accélérer ce déclin dont récemment la réponse immunitaire induite par le SARS-CoV-2. Deux vaccins sont disponibles à ce jour : un vaccin vivant atténué (Zostavax®) homologué en 2006 et plus récemment un vaccin recombinant (Shingrix®). Nous présentons des données d'efficacité de ces deux vaccins ainsi que celles concernant leurs précautions d'emploi et la sécurité de leur utilisation. © 2023 Elsevier Masson SAS

2.
Annales Médico-psychologiques, revue psychiatrique ; 2023.
Article in French | ScienceDirect | ID: covidwho-2316488

ABSTRACT

Résumé Objectifs De nombreuses personnes ont été infectées par le COVID-19 et pour une minorité d'entre elles, des symptômes multi-systémiques, fluctuants et impactant la qualité de vie, ont persisté au-delà de 20jours. Le COVID long a été d'abord défini par les patients eux-mêmes au printemps 2020 pour décrire leurs parcours de non-récupération. Plus précisément, le COVID long est défini comme « une constellation de symptômes physiques et mentaux qui peut persister ou émerger par la suite, façonnant un syndrome multi-systémique et invalidant, qui varie d'un patient à l'autre et qui fluctue dans le temps ». La persistance des symptômes du COVID, la diminution de la qualité de vie, l'incertitude quant à l'avenir, assorties parfois d'un faible soutien social perçu dans l'entourage médical et personnel, ont pu favoriser la survenue d'un trouble dépressif chez les patients atteints de COVID-long. L'objectif de cette recherche a été d'étudier l'effet des symptômes du COVID-long, des incertitudes et de l'altération de la qualité de vie sur les symptômes anxiodépressifs, tout en identifiant l'impact de variables modératrices comme les stratégies de coping et le soutien social. Matériel et méthode Deux cent quatorze participants atteints de COVID long (âgés de 18 à 68 ans, M=44ans, ET=11), dont 93 % de femmes (n=200) et 7 % d'hommes (n=14), ont participé à cette étude quantitative transversale entre les mois d'avril et de juin 2022. Ils ont décrit leurs symptômes et répondu à cinq échelles : l'échelle d'intolérance à l'incertitude (EII), l'échelle des stratégies de coping (WCC), l'échelle de mesure de la qualité de vie (MOS SF-36), l'échelle de soutien social perçu (QSSP), et l'échelle de mesure d'anxiété et de dépression (HADS). Résultats Les participants ont déclaré des symptômes de fatigue 91 % (n=171), de perte de concentration 52 % (n=111), de douleurs 51 % (n=110), de troubles du sommeil 49 % (n=104) et des difficultés de mémorisation 41 % (n=88). En comparaison avec la population générale, ils présentaient une qualité de vie dégradée, ainsi que des scores d'anxiété, de dépression et d'intolérance à l'incertitude élevés. Les scores aux stratégies de coping étaient également supérieurs aux normes relatives à la population générale, et ceux de la satisfaction du soutien social étaient généralement bons. Il est également apparu que les variables de l'intolérance à l'incertitude, de la qualité de vie et de la dépression étaient toutes corrélées entre elles. Par ailleurs, l'analyse de régression a permis de mettre en évidence les prédicteurs de la dépression. Ainsi les domaines de la qualité de vie Bien être émotionnel (β=–0,41, t (199)=–6,23, p<0,01) et Fatigue/énergie (β=–0,16, t (199)=–2,83, p<0,01) étaient des prédicteurs négatifs de la dépression, tout comme le score de coping centré sur le problème (β=–0,14, t (199)=–2,84, p<0,05). Les symptômes de la maladie en lien avec les difficultés de concentration (β=0,27, t (199)=5,16, p<0,01) et ceux impactant les projets (β=0,18, t (199)=3,31, p<0,01) étaient quant à eux des prédicteurs positifs de la dépression. Le deuxième constat de cette étude est que les personnes prises en charge spécifiquement pour leur COVID long présentaient des scores significativement moins élevés d'anxiété et d'intolérance à l'incertitude malgré des scores à certaines dimensions de la qualité de vie plus faibles. Également, les personnes prises en charge dans notre étude développaient davantage de stratégies de coping basées sur le problème et déclaraient davantage de disponibilité et de satisfaction liées au soutien social. Enfin, sur le plan de la qualité de vie, la population prise en charge a exprimé une meilleure santé psychique. Conclusions L'étude a montré, outre l'influence des symptômes du COVID long, de la qualité de vie, et des stratégies de coping sur les symptômes dépressifs, que la prise en charge spécifique des patients atteints de COVID long semble constituer en elle-même un facteur de protection de la dépression et de l'anxiété. Il apparaît donc essentiel que tout patient présentant un COVID long puisse bénéficier d'une prise en charge pluridisciplinaire spécifique à cette pathologie. Objectives Many people were infected by COVID-19 and for a minority of them, symptoms persisted beyond twenty days. These symptoms are multi-systemic, fluctuating, and impact the quality of life. Long COVID was first defined by patients themselves in the spring of 2020 to describe their recovery problems. Specifically, long COVID is defined as "a constellation of physical and mental symptoms which can persist or emerge afterwards, generating a multi-systemic and disabling syndrome, which varies from patient to patient and fluctuates over time”. The persistence of COVID symptoms, the decrease in the quality of life, the uncertainly about the future sometimes accompanied by a low level of social support perceived in the medical and personal entourage may have triggered the occurrence of a depressive disorder in patients with long COVID. The objective of this research was to study the effect of long COVID symptoms, of uncertainty and the impairment of quality of life on the development of depressive symptoms, while identifying the impact of moderating variables such as coping strategies and social support. Materials and methods Two hundred and fourteen participants with long COVID (aged 18–68, M=44, SD=11), including 93 % females (n=200) and 7% males (n=14), participated in this cross-sectional quantitative study between the months of April and June 2022. They described their symptoms and responded to five scales: the Evaluation of Intolerance of Uncertainty Scale (EII), the Coping Strategies Checklist (WCC), the Medical Outcome Study Short Form 36-item health survey (MOS SF-36), the Perceived Social Support Questionnaire (QSSP), and the Hospital Anxiety and Depression Scale (HADS). Results 91% of the participants reported symptoms of fatigue (n=171), 52% a loss of concentration (n=111), 51% pain (n=110), 49 % trouble sleeping (n=104), and 41% memory problems (n=88). Compared with the general population, they presented a poorer quality of life, as well as high scores for anxiety, depression, and intolerance of uncertainty. Scores on coping strategies were also higher than the norms for the general population, and scores on satisfaction with social support were generally good. It was also found that the variables of intolerance of uncertainty, quality of life, and depression all correlated with each other. Furthermore, the regression analysis revealed predictors of depression. The areas of quality of life and emotional well-being (β=–0.41, t(199)=–6.23, P<0.01) and fatigue/energy (β=–0.16, t(199)=–2.83, P<0.01) were negative predictors of depression, as was the problem-focused coping score (β=–0.14, t(199)=–2.84, P<0.05). Symptoms of the disorder related to concentration difficulties (β=0.27, t(199)=5.16, P<0.01) and those impacting projects (β=0.18, t(199)=3.31, P<0.01) were positive predictors of depression. The second finding of this study is that people treated specifically for their long COVID had significantly lower scores for anxiety and intolerance of uncertainty despite lower scores for certain dimensions of quality of life. The individuals who took part in our study also developed more problem-based coping strategies and reported more availability of and satisfaction with social support. Lastly, in terms of quality of life, the treated population expressed better mental health. Conclusions The study showed that, in addition to the effects of long COVID symptoms, quality of life, and coping strategies on the onset of symptoms of depression, the specific treatment of patients with long COVID seemed to constitute in itself a protective factor against depression and anxiety. It therefore would seem essential that any patient suffering from long COVID should receive multidisciplinary care specific to this pathology.

3.
NPG Neurologie - Psychiatrie - Gériatrie ; 2023.
Article in French | ScienceDirect | ID: covidwho-2316374

ABSTRACT

Résumé Les recommandations vaccinales en matière de prévention du zona ont pour objectif de réactiver l'immunité à médiation cellulaire spécifique contre le virus varicelle-zona. Cette immunité spécifique décline naturellement avec l'âge mais nombreux sont les facteurs qui peuvent accélérer ce déclin dont récemment la réponse immunitaire induite par le SARS-CoV-2. Deux vaccins sont disponibles à ce jour : un vaccin vivant atténué (Zostavax®) homologué en 2006 et plus récemment un vaccin recombinant (Shingrix®). Nous présentons des données d'efficacité de ces deux vaccins ainsi que celles concernant leurs précautions d'emploi et la sécurité de leur utilisation. Summary Vaccination recommendations for the prevention of herpes zoster (HZ) aim to reactivate specific cell-mediated immunity towards the varicella/zoster virus. This specific immunity naturally declines with age but there are many factors that can accelerate this decline, including, most recently, the immune response induced by SARS-CoV-2. Two vaccines are available to date. A live attenuated vaccine (Zostavax®) licensed in 2006 and more recently a recombinant vaccine (Shingrix®). We present data on the efficacy of these two vaccines as well as on the relevant precautions and safety of use.

4.
Rev Epidemiol Sante Publique ; 70(4): 183-189, 2022 Aug.
Article in French | MEDLINE | ID: covidwho-2182744

ABSTRACT

AIMS: The first wave of the COVID-19 pandemic generated "risks" and uncertainties as well as organizational changes among French perinatal caregivers. Our study aimed to investigate the psychosocial impact of the first wave on this population. METHOD: Our participants (N=565) were invited to answer an online questionnaire that included questions on various indices of health and quality of life at work (e.g., ProQoL, perceived stress) and other questions on the impact of the pandemic on work organization. An open-ended question was designed to identify the participants' three most frequently perceived preoccupations with regard to the health situation. RESULTS: In addition to highlighting the multifactorial nature of participants' preoccupations, our results illustrated the effect of professional status and type of motherhood on the different indices of health and quality of life at work. When it was found that the pandemic had an impact on work organization and on teams, lower health and quality of work life scores were recorded. On the other hand, when positive impacts on organization were reported, mainly in terms of reduced work intensity, they were associated with higher health and quality of work life scores. CONCLUSION: We explain this last result as either one actual effect of the pandemic on work organization, or as a phenomenon of cognitive rationalization.


Subject(s)
COVID-19 , Quality of Life , Adaptation, Psychological , COVID-19/epidemiology , Caregivers , Humans , Pandemics , Quality of Life/psychology
5.
Revue de Chirurgie Orthopédique et Traumatologique ; 108(8, Supplement):S258-S259, 2022.
Article in French | ScienceDirect | ID: covidwho-2120418

ABSTRACT

Introduction Comparer les résultats aux questionnaires sur la qualité de vie chez des patients préalablement recrutés dans des études cliniques, au moment de leur inclusion et deux ans après le début de la pandémie. L’hypothèse est que les scores de douleur et de qualité de vie seront significativement moins bons. Matériel et méthode Les patients ont été recrutés dans des bases de données d’études en cours dans un même centre. Les patients avaient tous complétés les questionnaires de qualité de vie de référence (WOOS, Quick-Dash, WOSI, McGill et échelle de Constant) lors de leur inclusion. Tous les patients étaient présentement sur des listes d’attente pour une chirurgie d’épaule élective pour instabilité ou arthrose. Les mêmes questionnaires que ceux complétés lors de leur adhésion ont été complétés de nouveaux au moins un an après l’inclusion. Les scores ont été comparés à l’aide du test-t de Student. Résultats Au total, 15 patients ont donné leur consentement pour l’entrevue téléphonique ;selon notre étude de puissance 18 patients étaient requis pour que les résultats soient concluants. Sept patients (âge moyen 68,7 ans (57–75)) attendaient une arthroplastie (PA) (renversée ou anatomique) depuis 490,29jours (191–924) en moyenne. Huit patients (âge moyen 38,5 ans (30–45)) attendaient une chirurgie pour instabilité (PI) depuis 697,75jours (343–441) en moyenne. Les scores WOSI étaient significativement plus élevés au suivi (p=0,04) pour les PA, particulièrement pour la portion sports, loisirs et travail du questionnaire (p=0,039). Le Quick-DASH moyen n’était pas significativement différent (p=0,268). Au contraire, les scores WOSI étaient significativement plus faibles au suivi pour les PI (p=0,042), peu importe le délai, particulièrement pour les questions sur les symptômes physiques et les émotions (p=0,027 et p=0,09). Deux patients avaient eu une récidive de luxation depuis leur inclusion. Les deux groupes étaient différents pour l’âge et la douleur. Conclusions Les patients en attente d’une arthroplastie élective ont des résultats significativement moins bons en ce qui concerne la douleur et la fonction, cela se reflète sur leurs activités de tous les jours, travail et loisirs. Les patients en attente pour instabilité ont de meilleurs résultats au suivi qu’au recrutement.

6.
Archives des Maladies Professionnelles et de l'Environnement ; 2022.
Article in English, French | Scopus | ID: covidwho-2027828

ABSTRACT

During the COVID-19 pandemic, repeated exposure of health care workers to unpredictable challenges in practice can affect their professional quality of life. The objectives of this study were to assess professional quality of life among healthcare workers during the COVID-19 pandemic and to investigate the relationships between professional quality of life and resilience. We conducted a cross-sectional, descriptive, and analytical study, carried out in October and November 2020, among 250 health professionals, practicing in Tunisia. Data were collected through an online questionnaire distributed on social networks. We used the “Professional Quality of Life Scale-5” to assess professional quality of life and the “Brief Resilience Scale” to assess resilience. Compassion satisfaction was low to moderate in 77.6% of participants. Most participants (90.4%) had moderate burnout. Compassion fatigue was low to moderate in 98% of cases. Healthcare professionals with higher resilience scores had significantly higher compassion satisfaction scores, and significantly lower burnout and compassion fatigue scores. In addition, higher burnout scores were associated with significantly lower compassion satisfaction scores and significantly higher compassion fatigue scores. These associations were found after multivariate analysis using multiple linear regression. Our results highlight the altered professional quality of life among healthcare workers during the COVID-19 pandemic. Immediate interventions are essential to improve psychological resilience and build health systems capacity. © 2022 Elsevier Masson SAS

7.
Soins ; 67(865): 33-35, 2022 May.
Article in French | MEDLINE | ID: covidwho-2000711

ABSTRACT

Spirituality is a health protection factor recognised in the scientific literature. However, few studies have evaluated its impact on French-speaking populations, in secularised societies and even fewer in the context of a pandemic. It is therefore interesting to highlight significant relationships between spiritual quality of life and health.


Subject(s)
Pandemics , Spirituality , Adaptation, Psychological , Health Status , Humans , Quality of Life
8.
Rev Epidemiol Sante Publique ; 70(4): 157-162, 2022 Aug.
Article in French | MEDLINE | ID: covidwho-1946442

ABSTRACT

OBJECTIVES: After the World Health Organisation (WHO) declared COVID-19 a global pandemic, various countries took preventive health measures to limit the spread of the coronavirus. The quality of life (QOL) of many populations was affected by lockdown and social distancing. The pandemic increased healthcare professionals' workload and decreased doctors' QOL. Our study aimed to evaluate the QOL of doctors in southern provinces of Morocco during the COVID-19 pandemic. In addition, the study compared QOL of the two genders at that time. METHODS: This was a cross-sectional and descriptive study. The sample included 257 doctors practicing in the southern provinces of Morocco. To assess QOL, we used the online self-administered WHOQOL-BREF questionnaire, which evaluates QOL in four domains: physical, mental, social and environmental. The cut-off between good and poor QOL was 60. RESULTS: All doctors showed poor QOL in all domains. The mean scores and standard deviations for the physical, mental, social, and environmental domains were 57.88 ± 17.12, 57.09 ± 20.13, 55.57 ± 23.66 and 47.99 ± 17.34, respectively. Comparing the two genders, males had a higher QOL than females with a statistically significant difference (p-value ≤ 0.05) in all domains. Both men and women had poor QOL in the environmental domain (less than 60). Doctors who worked directly in the COVID-19 circuit had poorer QOL in all domains. Even with scores lower than 60, males working in COVID-19 circuit had better QOL compared to females, except in the social domain. CONCLUSION: Southern Moroccan doctors' QOL was reduced in all domains. All doctors working in COVID-19 circuit had poor QOL, and women's scores were even lower than those of men.


Subject(s)
COVID-19 , Quality of Life , COVID-19/epidemiology , Communicable Disease Control , Cross-Sectional Studies , Female , Humans , Male , Pandemics , Surveys and Questionnaires
9.
Soins Gerontol ; 27(154): 30-38, 2022.
Article in French | MEDLINE | ID: covidwho-1740178

ABSTRACT

The Covid-19 pandemic with its associated quarantine and isolation has had a dramatic impact on the elderly. In order to mitigate this, the National University of La Plata and the Agence Universitaire de la Francophonie set up a health surveillance and early warning project for the elderly in Buenos Aires, Argentina. This interventional study, has included 1,964 people. A general health and quality of life questionnaire was completed by all participants at the beginning of the isolation, and another time a year later.


Subject(s)
COVID-19 , Aged , Argentina/epidemiology , Humans , Pandemics , Quality of Life , Quarantine
10.
Psycho-Oncologie ; 14(4):164-168, 2020.
Article in French | ProQuest Central | ID: covidwho-1698859

ABSTRACT

Objectif et méthode : Quelle a été l’expérience du confinement (16 mars 2020–11 mai 2020) en France, chez les patients atteints de cancer ? Au travers de questions ouvertes envoyées par messagerie électronique pendant les deux dernières semaines du confinement (27 avril–11 mai 2020), l’enquête BaroCov a étudié, auprès de patients suivis à l’institut Curie, les motifs de préoccupation et de satisfaction. À partir des réponses libres, 12 thématiques de préoccupation et 8 thématiques de satisfaction ont été extraites de manière inductive, à partir desquelles les réponses ont été codées puis analysées statistiquement. Résultats : Deux mille quatre cent soixante-dix-huit patients ont répondu, dont 90 % ont plus de 40 ans et 58,9 % entre 40 et 65 ans. Quatre-vingt-trois pour cent sont des femmes. Cinquante et un pour cent vivent à Paris et en proche banlieue. 61,4 % déclarent être en cours de traitement. Préoccupations : Les préoccupations concernaient la santé chez deux tiers des répondants (63,6 %). Elles avaient rapport avec le cancer chez la moitié (45,5 %), dont 9,8 % sur la poursuite du traitement et 5,7%sur les effets secondaires. La Covid-19 préoccupait un cinquième (18,1 %) des personnes. Un quart des répondants citaient comme thématique soit la vie quotidienne (16,6 %) [ne pas vivre comme d’habitude, l’activité professionnelle, l’argent, le logement, le climat social], soit les proches (12,8 %) [la séparation, leur santé, leur avenir]. Appréciations : Un tiers des répondants (33,7 %) citaient les relations avec les proches et un autre tiers (32 %) les conditions de vie (avec la qualité de vie chez 14,6 %, prendre son temps chez 10 % et la nature chez 7,4 %). Plus de 10 % des personnes (13,5 %) citaient spontanément une thématique liée à la maladie (chez 7,3 %, l’état de santé et chez 6,2 % les soins). La thématique du travail n’apparaissait quasiment pas (2,8 %). Conclusion : Le thème principal cité pendant le confinement n’était pas la Covid-19, mais plutôt les polarités existentielles de la vie face au cancer avec d’un côté la peur et les préoccupations liées à la maladie et de l’autre l’importance de l’entourage et la réévaluation positive de la vie quotidienne. Objective and method: The objective of the Barocov survey was to study cancer patients’ worries and satisfactions during Covid containment in France (March 16 to May 11, 2020). We sent e-mail open questions to patients cared for at Curie Institute. We have coded the responses in 12 worries topics and 8 satisfactions topics before analysing them. Results: 90% of the 2,478 respondents were over 40 years old and 58.9% between 40 and 65. 51% were living in Paris. 61.4% were on treatment. Worries: They concerned health for 63.9% of respondents: cancer for 45.5% (with 9.8% about continuing the treatment and 5.7% about side effects). 18.1% were concerned by Covid-19. 16.6% worried about daily life (unusual life, work, money, housing, social climate) and 12.8% worried about loved ones (not seeing them, health, future) Satisfactions: 33.7% appreciated relationships with loved ones and 32% their life conditions (quality of life for 14.6%, having time for 10%, nature for 7.4%). 13.5% had satisfactions about illness: health for 7.3% and cure for 6.2%. Work satisfaction is rare (2.8%) Conclusion: Covid-19 was not the principal worry but emphasized cancer experience’s polarities: on one side, fear about illness and treatment and on the other loved ones’ support and daily life.

11.
La Presse Médicale Formation ; 2021.
Article in French | ScienceDirect | ID: covidwho-1559007

ABSTRACT

Résumé Près d’un français sur cinq souffre de troubles de l’odorat (TO), ou dysosmie. Cette prévalence a augmenté depuis l’apparition de la COVID-19 dont la dysosmie est un symptôme très fréquent et possiblement persistant. Pourtant, la prise en soin des personnes dysosmiques reste insuffisante. Cet article ouvre des pistes pour développer les rééducations olfactives (RO) sur la base de protocoles déjà éprouvés, mais aussi pour améliorer l’accompagnement des patients dysosmiques. Pour cela, une stratégie de prise en charge pluri-professionnelle est préconisée, alliant l’intervention de scientifiques, de médecins (généralistes, ORL) et de professions paramédicales. Summary Nearly one in five French people suffer from olfactory disorders (TO), or dysosmia. This prevalence has increased since the onset of COVID-19, for which dysosmia is a very common and possibly persistent symptom. However, the care of people with dysosmia remains insufficient. This article opens up avenues for developing olfactory rehabilitation (OR) on the basis of existing protocols, but also for improving support for dysosmic patients. For this purpose, a multi-professional care strategy is recommended, combining the intervention of scientists, doctors (general practitioners, ENT) and paramedical professions.

12.
Soins ; 66(860): 49-51, 2021 Nov.
Article in French | MEDLINE | ID: covidwho-1514312

ABSTRACT

As part of a global approach to supporting carers in times of health crisis, the Elbeuf-Louviers-Val de Reuil hospital (76) has launched an experiment in "Bull'therapy". By providing a connected hypnosis mask, caregivers can benefit from a time of break time away from the stressful situations they face during their work.


Subject(s)
Caregivers , Hospitals , Animals , Cattle , Decompression , Humans , Male
13.
Encephale ; 48(6): 607-614, 2022 Dec.
Article in English | MEDLINE | ID: covidwho-1433192

ABSTRACT

INTRODUCTION: Health sciences students usually report high rates of mental health problems. The COVID-19 pandemic context may have serious psychological impacts in this at-risk population. We aimed to assess the self-reported mental health status, health-related quality of life and coping strategies of health sciences students during the early stage of the pandemic. METHOD: An online 128-item questionnaire sent to 17,673 health sciences students from the Claude Bernard University Lyon 1 in April 2020 assessed: a) sociodemographic characteristics, b) conditions of lockdown, c) depressive (Beck Depression Inventory- Short Form, BDI-SF), anxiety (State-Trait Anxiety Inventory-A, STAI-A) and traumatic symptoms (Impact of Event Scale -Revised, IES-R), d) health-related quality of life (SF12) and e) coping strategies (Brief Coping Orientation to Problems Experienced, Brief COPE). RESULTS: The participation rate was 9.9% (n=1,765). A total of 19.5% of participants reported an IES-R>33, 11.6% depressive symptoms, 58.1% anxiety symptoms, and 4.4% suicidal ideation. Their mental health-related quality of life was significantly poorer than for physical health. Female gender, COVID-like symptoms, social isolation due to the lockdown, pandemic-related financial restraint and exams-related stress were significantly associated with poorer self-reported mental health conditions. Volunteering in the healthcare system was significantly associated with lower mental health scores. Coping strategies were mostly oriented toward avoidance and positive appraisal. CONCLUSION: French health sciences students exhibited high levels of self-reported mental health problems and a poor mental health-related quality of life during the early stage of the COVID-19 pandemic. Specific risk factors related to the pandemic partly explain the observed prevalence.


Subject(s)
COVID-19 , Female , Humans , COVID-19/epidemiology , Pandemics , Mental Health , Quality of Life , Self Report , SARS-CoV-2 , Stress, Psychological/psychology , Communicable Disease Control , Adaptation, Psychological , Anxiety/psychology , Students/psychology , Surveys and Questionnaires , Depression/psychology
14.
Rev Mal Respir ; 38(9): 865-872, 2021 Nov.
Article in French | MEDLINE | ID: covidwho-1303677

ABSTRACT

INTRODUCTION: COVID-19 pandemics required changes in medical practices. In thoracic oncology, pembrolizumab was doubled to 400mg every 6weeks, nivolumab to 480mg every 4weeks. The objective of our study was to assess the impact on quality of life, and on psychological state, as well as the tolerance, of this new schedule. METHODS: Thoracic oncologic patients who underwent these therapeutic changes in our center during the first COVID-19 epidemic wave were included. Their quality of life was assessed using the Quality of Life Questionnaire-30, their psychological state by the Hospital Anxiety Depression (HAD) scale. We also reported the preferred administration schedule, as well as adverse events. RESULTS: Thirty patients were included. The overall quality of life was preserved. Rates on HAD scale were low. Tolerance was acceptable. In majority, patients preferred the new procedure. They had a significantly better quality of life compared to those who preferred the old one. CONCLUSIONS: This new immunotherapy schedule in thoracic oncology is well tolerated and allows a preservation of quality of life. This therapeutic option may be favored in the context of COVID-19 pandemics.


Subject(s)
COVID-19 , Lung Neoplasms , Anxiety , Humans , Immunotherapy , Lung Neoplasms/epidemiology , Lung Neoplasms/therapy , Pandemics , Quality of Life , SARS-CoV-2
15.
Rev Infirm ; 70(271): 36-37, 2021 May.
Article in French | MEDLINE | ID: covidwho-1240600

ABSTRACT

The mobilization and commitment of hospital staff in the fight against the COVID-19 epidemic have been remarkable since the beginning of this unprecedented health crisis. To support the teams of the Confluence Hospitals, the management has set up relaxation areas for the professionals.


Subject(s)
COVID-19 , Hospitals , Humans , Personnel, Hospital , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL